Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Chirata herb (Swertia chirata) is rich in xanthones (swerchirin, mangiferin), secoiridoids (amarogentin, swertiamarin), and alkaloids that exert hepatoprotective, hypoglycemic, and anti-inflammatory effects through enhanced bile secretion, improved insulin sensitivity, and CYP450 enzyme modulation. A comprehensive review in Current Pharmaceutical Biotechnology (2017, PMID 29076426) confirmed its broad pharmacological profile including antidiabetic, antimalarial, antioxidant, and antimicrobial activities, while a 2016 study in the Journal of Ethnopharmacology (PMID 26657265) demonstrated clinically significant CYP450-mediated drug interaction potential.
Reported Benefits (Provisional)
Origin & History
Chirata Herb (Swertia chirata) is a bitter herb native to the mountainous regions of India, Nepal, and Sri Lanka. It thrives in temperate climates and is highly valued in traditional medicine systems for its potent therapeutic properties.
Research Narrative (Provisional)
Jauhari et al. (2017) published a comprehensive review in Current Pharmaceutical Biotechnology (PMID 29076426) documenting Swertia chirata's antidiabetic, hepatoprotective, anti-inflammatory, antimalarial, and antioxidant activities attributed to its rich phytochemical profile of xanthones, secoiridoids, and flavonoids. Ahmmed et al. (2016) in the Journal of Ethnopharmacology (PMID 26657265) demonstrated that S. chirata extracts significantly inhibit CYP450 enzymes, establishing important herb-drug interaction data and confirming the bioactivity of its major constituents. Triantafyllidi et al. (2015) reviewed herbal therapies including bitter herbs in Annals of Gastroenterology (PMID 25830661), supporting the traditional gastrointestinal applications of bitter plant medicines like chirata in inflammatory bowel conditions. These studies collectively validate centuries of Ayurvedic and Unani medicinal use with modern pharmacological evidence.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Bioactive Compounds: Rich in alkaloids, swertiamarin, and gentiopicroside, key for its bitter and therapeutic effects. - Flavonoids: Contribute to its antioxidant and anti-inflammatory properties. - Vitamin C: Supports immune function and antioxidant defense. - Fiber: Aids digestive health.
Reported Mechanism (Provisional)
Chirata's primary bioactive xanthones—swerchirin and mangiferin—enhance insulin sensitivity by stimulating pancreatic β-cell regeneration and modulating GLUT4 glucose transporter expression, while amarogentin, a potent secoiridoid, activates bitter taste receptors (TAS2Rs) on enteroendocrine cells to stimulate bile secretion and digestive enzyme release. The herb's anti-inflammatory activity is mediated through xanthone-driven inhibition of NF-κB signaling, suppression of COX-2 and iNOS expression, and downregulation of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. Swertiamarin and gentiopicroside act as choleretic agents that upregulate hepatic Phase II detoxification enzymes (glutathione S-transferase, UDP-glucuronosyltransferase), facilitating enhanced toxin conjugation and elimination. Additionally, as documented by Ahmmed et al. (2016, PMID 26657265), chirata constituents modulate CYP450 enzymes—particularly CYP3A4, CYP2D6, and CYP1A2—which explains both its metabolic effects and its herb-drug interaction potential.
Clinical Narrative (Provisional)
Controlled studies show chirata's 70% ethanol extract demonstrates significant antioxidant activity with IC₅₀ values of 267.80 μg/mL (DPPH) and 6.50 μg/mL (ABTS). Ethanolic root extracts showed potent anti-inflammatory effects against carrageenan-induced edema and antinociceptive activity comparable to aminopyrine in chemical pain models. Psychopharmacological studies using 250-500 mg/kg doses revealed significant sedating effects, with ethanolic extracts showing superior efficacy over methanolic preparations (p<0.05). Evidence quality is moderate, primarily from preclinical studies with limited human clinical trial data.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.